Clear Reflection Complexion Acne Treatment Serum
- Manufacturer
- Renu Laboratories, Inc.
- Effective date
- 2023-10-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 23:58:30
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
2 percent Salicylic Acid
WARNINGS SECTION
For external use only.
OTC - DO NOT USE SECTION
Do not use this medication if you have very sensitive skin or if you are sensitive to salicylic acid.
OTC - WHEN USING SECTION
Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one medication at a time.
Avoid contact with the eyes
If contact occurs, rinse thoroughly with water
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
In the morning, after cleansing face, apply serum evenly and make sure all problem areas are treated. Mild tingling may occur. If bothersome dryness occurs, reduce application to once every other day.
INACTIVE INGREDIENT SECTION
Cyclopentasiloxane, Dimethiconol, Isopropyl Alcohol, Octyldodecanol, Helianthus Annuus (Sunflower) Seed Oil, Dimethicone, Dihydroeugenol, Isoeugenyl, Cinnamal, Ethyl Vanilla.
OTC - PURPOSE SECTION
Acne Treatment
INDICATIONS & USAGE SECTION
Recommended use is in the morning after cleansing and before applying any makeup.
OTC - QUESTIONS SECTION
Call Customer Service at 1 800 990 6552 or contact customerservice@dermamedics.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76348-685-02 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-5d04-d83d-e063-dadaa90ab31f | Clear Reflection Complexion Acne Treatment Serum |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76348-685-02 | Clear Reflection Complexion Acne Treatment Serum | 52 mL in 1 BOTTLE, PUMP | GEL | 52 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Clear Reflection Complexion Acne Treatment Serum
- Salicylic Acid 2%
- CINNAMALDEHYDE
- ISOPROPYL ALCOHOL
- SUNFLOWER OIL
- ISOEUGENYL ACETATE
- ETHYL VANILLIN
- DIHYDROEUGENOL
- CYCLOMETHICONE 5
- OCTYLDODECANOL
- SALICYLIC ACID
- DIMETHICONOL (50000 CST)
- DIMETHICONE 12500
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 76348-685 | 76348-685-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CINNAMALDEHYDE | SR60A3XG0F | IACT |
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| SUNFLOWER OIL | 3W1JG795YI | IACT |
| ISOEUGENYL ACETATE | 9DF21GI8W6 | IACT |
| ETHYL VANILLIN | YC9ST449YJ | IACT |
| DIHYDROEUGENOL | A3XE712277 | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| OCTYLDODECANOL | 461N1O614Y | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| DIMETHICONOL (50000 CST) | R2285D73YT | IACT |
| DIMETHICONE 12500 | D1R3R4B8M8 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 08f56c9e-921d-4e48-e063-6294a90a56db | 08f56c9e-921c-4e48-e063-6294a90a56db | 2023-10-30 | Warnings | 08f56c9e-921d-4e48-e063-6294a90a56db 08f56c9e-921c-4e48-e063-6294a90a56db |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
